ArticleCurrent medical imaging2025
CERVIXNET: An Efficient Approach for the Detection and Classifications of the Cervigram Images Using Modified Deep Learning Architecture.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe earlier detection of cervical cancer in women patients can save human life. This article proposes a novel methodology for detecting abnormal cervigram images from healthy cervigram images and segments the cancer regions in the abnormal cervigram images using the deep learning method. The conventional deep learning architecture has been modified into the proposed CervixNet architecture to improve the cervical cancer detection rate.
methodsThis methodology is constituted of a training and testing process, where the training process generates the training sequences individually for healthy cervigram images and the cancer case cervigram images. The testing process tests the cervigram images into either a healthy or cancer cases using the training sequences generated through the training process. During the testing process of the proposed system, the cancer segmentation algorithm was applied on the abnormal cervigram image to detect and segment the pixels belonging to cancer. Finally, the performance has been carried out on the segmented cancer cervical images for the ground truth images. This proposed methodology has been evaluated on the cervigrams on IMODT and Guanacaste databases. Its performance has been analyzed concerning cancer pixel sensitivity, cancer pixel specificity and cancer pixel accuracy.
resultsThis research work obtains 98.69% Cancer Pixel Sensitivity (CPS), 98.76% Cancer Pixel Specificity (CPSP), and 99.27% Cancer Pixel Accuracy (CPA) for the set of cervigram images in the IMODT database. This research work obtains 99.22% CPS, 99.03% CPSP, and 99.01% CPA for the set of cervigram images in Guanacaste database.
conclusionThese experimental results of the proposed work have been significantly compared with the state-of-the-art methods and show the significance and novelty of the proposed works.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.